|
|
Volumn 8 Suppl 1, Issue , 2006, Pages
|
|
Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL MARKER;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
GEFITINIB;
PROTEIN KINASE INHIBITOR;
QUINAZOLINE DERIVATIVE;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG MONITORING;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METHODOLOGY;
MORTALITY;
RASH;
REVIEW;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL MARKERS;
CARCINOMA, NON-SMALL-CELL LUNG;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG MONITORING;
EXANTHEMA;
HUMANS;
LUNG NEOPLASMS;
PROTEIN KINASE INHIBITORS;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 34249738700
PISSN: 15257304
EISSN: None
Source Type: Journal
DOI: 10.3816/CLC.2006.s.008 Document Type: Article |
|
Times cited : (106)
|
|
References (57)
|
